BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 17339873)

  • 21. Utilization of pharmacogenomics and therapeutic drug monitoring for opioid pain management.
    Jannetto PJ; Bratanow NC
    Pharmacogenomics; 2009 Jul; 10(7):1157-67. PubMed ID: 19604091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Individual differences in analgesic effects of narcotics].
    Ide S; Kasai S; Ikeda K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Feb; 28(1):43-8. PubMed ID: 18411709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review of Opioid Pharmacogenetics and Considerations for Pain Management.
    Owusu Obeng A; Hamadeh I; Smith M
    Pharmacotherapy; 2017 Sep; 37(9):1105-1121. PubMed ID: 28699646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenetics in palliative care.
    Kleine-Brueggeney M; Musshoff F; Stuber F; Stamer UM
    Forensic Sci Int; 2010 Dec; 203(1-3):63-70. PubMed ID: 20709477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antinociceptive and adverse effects of mu- and kappa-opioid receptor agonists: a comparison of morphine and U50488-H.
    Gallantine EL; Meert TF
    Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):419-27. PubMed ID: 18699797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Side effects of opioid and gene variants].
    Sora I; Komatsu H; Igari M; Ide S; Ikeda K; Shimoyama N
    Masui; 2009 Sep; 58(9):1109-11. PubMed ID: 19764433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nociception increases during opioid infusion in opioid receptor triple knock-out mice.
    Juni A; Klein G; Pintar JE; Kest B
    Neuroscience; 2007 Jun; 147(2):439-44. PubMed ID: 17544222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low efficacy opioids: implications for sex differences in opioid antinociception.
    Barrett AC
    Exp Clin Psychopharmacol; 2006 Feb; 14(1):1-11. PubMed ID: 16503700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methadone treatment for pain states.
    Toombs JD; Kral LA
    Am Fam Physician; 2005 Apr; 71(7):1353-8. PubMed ID: 15832538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioid analgesic drugs in the elderly.
    Forman WB
    Clin Geriatr Med; 1996 Aug; 12(3):489-500. PubMed ID: 8853941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals.
    Coller JK; Barratt DT; Dahlen K; Loennechen MH; Somogyi AA
    Clin Pharmacol Ther; 2006 Dec; 80(6):682-90. PubMed ID: 17178268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fundamental Considerations for Genetically-Guided Pain Management with Opioids Based on CYP2D6 and OPRM1 Polymorphisms.
    Ruano G; Kost JA
    Pain Physician; 2018 Nov; 21(6):E611-E621. PubMed ID: 30508992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioid pharmacokinetic drug-drug interactions.
    Overholser BR; Foster DR
    Am J Manag Care; 2011 Sep; 17 Suppl 11():S276-87. PubMed ID: 21999760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic polymorphisms and human sensitivity to opioid analgesics.
    Nishizawa D; Hayashida M; Nagashima M; Koga H; Ikeda K
    Methods Mol Biol; 2010; 617():395-420. PubMed ID: 20336437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of genetic factors on opioid action.
    Kosarac B; Fox AA; Collard CD
    Curr Opin Anaesthesiol; 2009 Aug; 22(4):476-82. PubMed ID: 19502975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments.
    Kreek MJ; Bart G; Lilly C; LaForge KS; Nielsen DA
    Pharmacol Rev; 2005 Mar; 57(1):1-26. PubMed ID: 15734726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are mu-opioid receptor polymorphisms important for clinical opioid therapy?
    Lötsch J; Geisslinger G
    Trends Mol Med; 2005 Feb; 11(2):82-9. PubMed ID: 15694871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives.
    Lötsch J; Skarke C; Liefhold J; Geisslinger G
    Clin Pharmacokinet; 2004; 43(14):983-1013. PubMed ID: 15530129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence from basic research for opioid combinations.
    Davis MP
    Expert Opin Drug Discov; 2012 Feb; 7(2):165-78. PubMed ID: 22468917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [How can we cope with wide individual variations in pain intensity and opioid requirements after surgery?].
    Hayashida M; Maruyama K
    Masui; 2009 Sep; 58(9):1086-92. PubMed ID: 19764430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.